Walgreens Boots Alliance, Inc. (WBA) reported on August 2, 2024, that it is actively reviewing its U.S. Healthcare portfolio, specifically its investment in VillageMD, a national provider of value-based healthcare. The review includes considering a sale, restructuring, or other strategic options for VillageMD. This follows a $2.25 billion secured loan provided to VillageMD by WBA on January 3, 2023. Defaults under this loan were acknowledged on August 2, 2024, leading to a forbearance agreement on August 6, 2024, where WBA agreed not to exercise remedies provided VillageMD complies with certain conditions. WBA is engaged in discussions regarding the future of its investment in VillageMD with stakeholders and third parties. The company cautions that forward-looking statements in the report are subject to risks and uncertainties and that actual results may differ materially.

Walgreens Boots Alliance, Inc. (WBA) reported on August 2, 2024, that it is actively reviewing its U.S. Healthcare portfolio, specifically its investment in VillageMD, a national provider of value-based healthcare. The review includes considering a sale, restructuring, or other strategic options for VillageMD. This follows a $2.25 billion secured loan provided to VillageMD by WBA on January 3, 2023. Defaults under this loan were acknowledged on August 2, 2024, leading to a forbearance agreement on August 6, 2024, where WBA agreed not to exercise remedies provided VillageMD complies with certain conditions. WBA is engaged in discussions regarding the future of its investment in VillageMD with stakeholders and third parties. The company cautions that forward-looking statements in the report are subject to risks and uncertainties and that actual results may differ materially.